<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Sun, 08 Nov 2009 01:52:38 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>BioCurex Poised For Positive Future Based On Results (OTC:BOCX)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3579188</guid>
      <description><![CDATA[BioCurex, Inc. (“BioCurex” or “the Company”) is a biotechnology company developing products for cancerdiagnosis, imaging, and therapy that target a global oncology market forecast to reach over $50 billion by 2009.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3579188>[More...]</a>]]></description>
      <pubDate>Mon, 26 Oct 2009 16:12:10 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BOCX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DXG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PSA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SAB</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3579188</link>
    </item>
    <item>
      <title>The Week In Review: International Initiatives</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3577404</guid>
      <description><![CDATA[Boehringer Ingelheim will invest $149 million in China for new facilities including an R&amp;D center;&#160;Simcere Pharma<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3577404>[More...]</a>]]></description>
      <pubDate>Sat, 24 Oct 2009 17:19:11 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BTIM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CBPO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CHME</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CMED</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DXG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSIP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SCR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SPR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SVA</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3577404</link>
    </item>
    <item>
      <title>Holiday Season May Bring Renewed Interest In BizAuctions (OTC: BZCN.OB)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3557134</guid>
      <description><![CDATA[(Public, OTC:BZCN.OB)
As the holiday season fast approaches during one of the most hard hit economic times in recent memory, certain discount companies look to profit and gain recognition, differentiating themselves from the pack. One of these such companies is BizAuctions Inc. (OTC:BZCN.OB),<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3557134>[More...]</a>]]></description>
      <pubDate>Fri, 16 Oct 2009 16:18:16 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BIG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BZCN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DXG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBAY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LSI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NPHC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSTK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3557134</link>
    </item>
    <item>
      <title>Investing In Battery Stocks</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3548297</guid>
      <description><![CDATA[One of the most glaring — and accurate — criticisms of solar energy is the simple fact that there's no sunlight at night.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3548297>[More...]</a>]]></description>
      <pubDate>Tue, 13 Oct 2009 19:22:36 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AONE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BYD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DXG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JCI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UQM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">XIDE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3548297</link>
    </item>
    <item>
      <title>FDA Calendar Extreme Trades: 85 Single Digit Stocks</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3546991</guid>
      <description><![CDATA[The BioMedReports.com FDA Calendar database includes over 400 entries of (1) pending new drug, biological agent, or medical device new product decisions at the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, and sBLA filings); (2) pending new submissions to the FDA; (3) pending complete response letter (CRL) re-submissions to the FDA; and (4) pending clinical trial results.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3546991>[More...]</a>]]></description>
      <pubDate>Tue, 13 Oct 2009 16:29:25 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACCP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">APOL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CFS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CLDA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CYTX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DCTH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DXG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DYAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GAM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GBM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GLS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HEB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HGSI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IMUC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LRP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MNT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MNTA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MXM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NEP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NGSX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OPMR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OREX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">POR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PSA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PTXRF</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">QTM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLXP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SOMX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SUI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TEVA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TGI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TSX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VNDA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3546991</link>
    </item>
    <item>
      <title>The Next Big Thing In Health Care: How To Profit From Immunotherapy &amp; Regenerative Medicine</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3536231</guid>
      <description><![CDATA[The procedure has been called &quot;one of the most barbaric mistakes ever perpetrated by mainstream medicine.&quot; Back when medicine was highly primitive, the process involved shoving an ice pick-like instrument between the upper eyelid and the eye in hopes of severing certain nerves of the frontal lobe.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3536231>[More...]</a>]]></description>
      <pubDate>Wed, 07 Oct 2009 19:22:50 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BBI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMRN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CYTX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DNDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DXG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GERN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NNYP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STEM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3536231</link>
    </item>
    <item>
      <title>Access Pharma (OTC: ACCP.OB): MuGard, Pipeline Makes for Appealing Acquisition Possibilities</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3514109</guid>
      <description><![CDATA[Access Pharma (OTC: ACCP.OB) is an emerging bio-pharmaceutical company which is focusing on the development of a late-stage, diversified oncology pipeline in addition to a treatment called MuGard is cleared for marketing in the U.S., Europe, and other key global markets for a common side effect of some cancer treatments known as mucositis (painful sores in the mouth and GI mucosal lining).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3514109>[More...]</a>]]></description>
      <pubDate>Tue, 29 Sep 2009 19:31:31 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACCP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALTH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BBI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CTIC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DXG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MEDX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ORCL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SPPI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">YMI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3514109</link>
    </item>
    <item>
      <title>Positions Revisited</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3500068</guid>
      <description><![CDATA[I want to revisit some of my stock decisions and see what was the outcome and analyze if there is anything I should have done better. I will try to be intellectually honest with my assessments and recognize my errors. Also i want to look back and see if there are any mental traps that affected my decisions and recognize when i fall for these psychological biases. 
Below is all the positions that I have talked about on this blog for over a year or so. All are businesses that I looked to own but did not or I bought and sold. 
General Growth (GGPWQ): I have dismissed the value in<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3500068>[More...]</a>]]></description>
      <pubDate>Wed, 23 Sep 2009 16:32:28 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AXP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CAH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">COH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DXG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FSRV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GGP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HWK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NRF</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SHLD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TCK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3500068</link>
    </item>
    <item>
      <title>BioMed News Bytes: CUR, IPXL, QCOR, VRX</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3494050</guid>
      <description><![CDATA[On 9/21/09, Neuralstem (AMEX: CUR) ($2.50, +34%, heavy volume) announced that the FDA has approved its Investigational New Drug (IND) application to commence a Phase I trial to treat Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease) with its spinal cord stem cells.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3494050>[More...]</a>]]></description>
      <pubDate>Mon, 21 Sep 2009 15:44:46 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CUR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DXG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IPXL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">QCOR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3494050</link>
    </item>
    <item>
      <title>The Options Markets Want YOU!</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3469426</guid>
      <description><![CDATA[With the Labor Day holiday behind us, traders and investors have wrapped up their summer vacations and returned to their trading desks. The people who &quot;sold in May and went away&quot; missed out on some profits this summer as the market went on (and up) without them, and they have some catching up to do, either to get their portfolios back to where they were ... or up to where they should be.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3469426>[More...]</a>]]></description>
      <pubDate>Thu, 10 Sep 2009 05:28:53 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">DXG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3469426</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=DXG" rel="self" type="application/rss+xml" />
  </channel>
</rss>